Thrombocytopenia Flashcards
2 categories of immune thrombocytopenia
fetal/neonatal alloimmune thrombocytopenia
immune thrombocytopenia
thrombocytopenia due to maternal platelet antibodies
alloimmune thrombocytopenia
can alloimmune thrombocytopenia occur in first pregnancy?
yes
80% of alloimmune thrombocytopenia is due to what platelet antibody?
HPA-1a
most common cause of severe neonatal thrombocytopenia
fetal/neonatal alloimmune thrombocytopenia
disease that affects fetus and newborn in which platelet count is decreased due to maternal antibody crossing the placenta and attaching to the antigens on the fetal platelets
fetal and neonatal alloimmune thrombocytopenia
fetal and maternal platelet counts in fetal and neonatal alloimmune thrombocytopenia
fetus = low maternal = normal
what ethnicity of mothers is more likely to have platelet antibodies OTHER than anti-HPA-1a?
Asian
modes of presentation for fetal and neonatal alloimmune thrombocytopenia
previously affected sibling recurrent fetal loss antenatal hydrocephalus stillbirth bruising/bleeding intracranial hemorrhage DIC postnatal ICH
most common mode of presentation of alloimmune thrombocytopenia in neonate
bruises or petechiae
diagnostic testing for alloimmune thrombocytopenia
screening of maternal serum for platelet antibodies
maternal and paternal platelet antigen phenotyping
maternal and paternal platelet antigen genotyping
alloimmune thrombocytopenia treatment in utero
cordocentesis (diagnosis, administration of blood products, monitoring platelet count)
IVIG (to mother during pregnancy, immediately after birth to infant)
platelet count goals in alloimmune thrombocytopenia
> 50,000 for vaginal delivery
>20,000 after birth
alloimmune thrombocytopenia treatment after birth
compatible platelet transfusions (antigen negative or mother’s washed platelets)
IVIG
most rapidly effective treatment in infants with severe hemorrhage and/or severe thrombocytopenia
transfusion of compatible platelets